Haploidentical hematopoietic cell transplantation

This study introduces CHIME, a novel HLA eplet mismatch model, revealing its association with non-relapse mortality and severe aGvHD in haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide, improving outcome prediction over traditional allele mismatch methods.